Endurance Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Endurance Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$144K	Hold	938	–	–	0.02%	232
2023 Q1	$145K	Buy	938 +250	+36%	+$39.3K	0.02%	228
2022 Q4	$106K	Hold	688	–	–	0.02%	245
2022 Q3	$91K	Hold	688	–	–	0.02%	258
2022 Q2	$93K	Hold	688	–	–	0.01%	261
2022 Q1	$103K	Hold	688	–	–	0.01%	272
2021 Q4	$111K	Hold	688	–	–	0.01%	275
2021 Q3	$114K	Hold	688	–	–	0.01%	266
2021 Q2	$118K	Hold	688	–	–	0.01%	268
2021 Q1	$110K	Hold	688	–	–	0.01%	273
2020 Q4	$116K	Hold	688	–	–	0.01%	245
2020 Q3	$108K	Hold	688	–	–	0.02%	234
2020 Q2	$115K	Hold	688	–	–	0.02%	224
2020 Q1	$90K	Hold	688	–	–	0.02%	230
2019 Q4	$102K	Hold	688	–	–	0.02%	224
2019 Q3	$85K	Hold	688	–	–	0.01%	233
2019 Q2	$97K	Hold	688	–	–	0.02%	224
2019 Q1	$104K	Hold	688	–	–	0.02%	215
2018 Q4	$85K	Hold	688	–	–	0.02%	216
2018 Q3	$109K	Buy	+688	New	+$104K	0.02%	211

Other funds holding FBT

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Endurance Wealth Management's FBT Position: Q2 2023 in Review

Endurance Wealth Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2023 at 938 shares worth $144K. The position accounts for 0.02% of the portfolio, ranked #232.

Endurance Wealth Management first reported a position in FBT in Q3 2018 and has held it in 20 quarters since. The position peaked at $145K in Q1 2023. 249 funds tracked by Wall St. Rank hold FBT as of Q2 2023.

Endurance Wealth Management held 938 shares of First Trust NYSE Arca Biotechnology Index Fund worth $144K as of Q2 2023.
Endurance Wealth Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2023.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Endurance Wealth Management's portfolio in Q2 2023, its #232 holding.
Endurance Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2018 and has held it in 20 quarters since.
Endurance Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $145K in Q1 2023.
249 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.